Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Feb;76(2):206-11.
doi: 10.1016/j.ijporl.2011.10.025. Epub 2011 Nov 26.

Human bocavirus in the nasopharynx of otitis-prone children

Affiliations
Randomized Controlled Trial

Human bocavirus in the nasopharynx of otitis-prone children

Liisa Lehtoranta et al. Int J Pediatr Otorhinolaryngol. 2012 Feb.

Abstract

Objectives: Human bocavirus (HBoV) is frequently identified in children with respiratory tract infections, and its role in acute otitis media (AOM) has been suggested. The disease associations for the closely related bocaviruses HBoV2-4 remain unknown. Increasing evidence shows that probiotics may reduce the risk of AOM of viral origin. Objectives of the study was to examine the prevalence and persistence of bocaviruses in consecutive nasopharyngeal samples (NPS) of otitis-prone children, and whether an association exists between HBoV and the child's characteristics, respiratory symptoms, and AOM pathogens, and whether probiotics reduce the occurrence of HBoV.

Methods: In a double-blind, placebo-controlled, randomized, 6-month intervention study, 269 otitis-prone children (aged 9 months to 5.6 years), consumed daily either one capsule of probiotics (Lactobacillus rhamnosus GG, L. rhamnosus Lc705, Bifidobacterium breve 99 and Propionibacterium freudenreichii JS) or placebo. After a clinical examination and NPS collected at three-time points, the presence and persistence of HBoV1-4 DNA in NPS was determined by RT-qPCR at the baseline, after 3, and 6 months.

Results: A high load (>10,000 copies/ml) of HBoV DNA was detected in 26 (17.1%) of 152 children, and 16 (10.5%) showed a prolonged presence of HBoV for at least 3 months. None had DNA of HBoV2-4. Higher number of siblings associated with increased HBoV prevalence (p=0.029). Prevalence or persistence of HBoV was not significantly associated with other characteristics, respiratory symptoms, or AOM pathogens. Probiotic intervention significantly reduced the number of HBoV DNA-positive samples (probiotic vs. placebo: 6.4% vs. 19.0%, OR=0.25, CI 95%=0.07-0.94, p=0.039).

Conclusions: HBoV, but not HBoV2-4, DNA occurs often in the nasopharynx of otitis-prone children, and may persist for 3-6 months. Probiotic treatment possibly reduced the presence of HBoV.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) Distribution (%) of viral loads of HBoV DNA in the nasopharynx of 152 otitis-prone children within the 6-month study period. (B) Distribution of detectable HBoV viral loads (range 1.6 × 102 to 1.3 × 108 copies/ml) for all studied 456 nasopharyngeal samples. mo = months visits.

References

    1. Nokso-Koivisto J., Räty R., Blomqvist S., Kleemola M., Syrjänen R., Pitkäranta A. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J. Med. Virol. 2004;72(2):241–248. - PMC - PubMed
    1. Heikkinen T., Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin. Microbiol. Rev. 2003;16(2):230–241. - PMC - PubMed
    1. Bulut Y., Güven M., Otlu B., Yenişehirli G., Aladağ İ., Eyibilen A. Acute otitis media and respiratory viruses. Eur. J. Pediatr. 2007;166(3):223–228. - PMC - PubMed
    1. Chonmaitree T., Revai K., Grady J.J., Clos A., Patel J.A., Nair S. Viral upper respiratory tract infection and otitis media complication in young children. Clin. Infect. Dis. 2008;46(6):815–823. - PMC - PubMed
    1. Nokso-Koivisto J., Hovi T., Pitkäranta A. Viral upper respiratory tract infections in young children with emphasis on acute otitis media. Int. J. Pediatr. Otorhinolaryngol. 2006;70(8):1333–1342. - PMC - PubMed

Publication types

MeSH terms